0Suppliers
12Customers
2Debt Items
20Related Chains

Source-Backed Evidence Depth

Alexandria Real Estate Equities, Inc. (ARE) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

15Total relationships
1Distinct source URLs
6High confidence
0.785Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Alexandria Real Estate Equities, Inc. Suppliers

No suppliers on recordAlexandria Real Estate Equities, Inc. has not yet been matched to upstream suppliers in our database, or is still being processed.

Alexandria Real Estate Equities, Inc. Customers

TickerNameConfidenceEvidence
ALTOS-LABS-INC ALTOS-LABS-INC 90% Annual rental revenue and RSF include 100% of each property managed by us in North America.
AMGEN-INC AMGEN-INC 90% Annual rental revenue and RSF include 100% of each property managed by us in North America.
VAXCYTE-INC VAXCYTE-INC 90% Annual rental revenue and RSF include 100% of each property managed by us in North America.
EIKN EIKN 72% Item 2 for additional details, including our methodologies of calculating annual rental revenue from unconsolidated real estate joint ventures and average market capitalization, respectively. (1) Bas…
EIKN EIKN 72% Reciprocal relationship from EIKN graph: Reciprocal relationship from ARE graph: Reciprocal relationship from EIKN graph: Reciprocal relationship from ARE graph: Reciprocal relationship from EIKN gra…
MRK Merck & Co., Inc. 72% Item 2 for additional details, including our methodologies of calculating annual rental revenue from unconsolidated real estate joint ventures and average market capitalization, respectively. (1) Bas…
MRK Merck & Co., Inc. 72% Reciprocal relationship from MRK graph: Reciprocal relationship from ARE graph: Reciprocal relationship from MRK graph: Reciprocal relationship from ARE graph: Reciprocal relationship from MRK graph:…
NVSEF Novartis AG 72% er Technologies, Inc. 56.5 (4) 1,009,188 27,865 1.5 Baa1 BBB $ 178.6 10 Boston Children's Hospital 11.0 309,231 26,294 1.4 Aa2 AA $ — 11 Novartis AG 2.2 (5) 321,743 25,111 1.4 Aa3 AA- $ 273.6 12 Sano…
NVSEF Novartis AG 72% Reciprocal relationship from NVSEF graph: Reciprocal relationship from ARE graph: er Technologies, Inc. 56.5 (4) 1,009,188 27,865 1.5 Baa1 BBB $ 178.6 10 Boston Children's Hospital 11.0 309,231 26,29…
SNYNF Sanofi 72% er Technologies, Inc. 56.5 (4) 1,009,188 27,865 1.5 Baa1 BBB $ 178.6 10 Boston Children's Hospital 11.0 309,231 26,294 1.4 Aa2 AA $ — 11 Novartis AG 2.2 (5) 321,743 25,111 1.4 Aa3 AA- $ 273.6 12 Sano…
SNYNF Sanofi 72% Reciprocal relationship from SNYNF graph: Reciprocal relationship from ARE graph: er Technologies, Inc. 56.5 (4) 1,009,188 27,865 1.5 Baa1 BBB $ 178.6 10 Boston Children's Hospital 11.0 309,231 26,29…
LIQUIDITY-LIQUIDITY-LIMITED LIQUIDITY-LIQUIDITY-LIMITED 62% Item 1 for additional information. 91 Investments We hold investments in publicly traded companies and privately held entities primarily involved in the life science industry. The tables below summar…

Alexandria Real Estate Equities, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
ARE-DEBT Debt stack $12.8B 90% Market cache reports total debt of $12.8B.
ARE-DEBT-7188 Xbrl Convertible 90% xbrl convertible detail from xbrl 2010-12-31.

Alexandria Real Estate Equities, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Alexandria Real Estate Equities, Inc..

Alexandria Real Estate Equities, Inc. Ownership

HolderNameConfidenceEvidence
ARE-OWNER-MORGAN-STANLEY MORGAN STANLEY 90% 13F overlay lists MORGAN STANLEY as top holder; 6 tracked holders.

Alexandria Real Estate Equities, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
EDSA Edesa Biotech, Inc. 100.00 2
DBVTF DBV TECHNOLOGIES 100.00 2
AZN AstraZeneca PLC 100.00 2
CCEP Coca-Cola Europacific Partners PLC 100.00 2
PSNL Personalis, Inc. 100.00 2
DYN Dyne Therapeutics, Inc. 100.00 2
CTNM Contineum Therapeutics, Inc. 100.00 2
DSGN Design Therapeutics, Inc. 100.00 2
ANL Adlai Nortye Ltd. 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
ANRO Alto Neuroscience, Inc. 100.00 2
SVA Sinovac Biotech Ltd. 100.00 2
ALXO ALX Oncology Holdings Inc. 100.00 2
IMMP Immutep Limited 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
CYTK Cytokinetics, Incorporated 100.00 2
BLRX BioLineRx Ltd. 100.00 2
CBIO Crescent Biopharma, Inc. 100.00 2
BNBX BNB Plus Corp. 100.00 2
EDIT Editas Medicine, Inc. 100.00 2
🔐
ARE
Unlock ARE Supply Chain Data
Verified relationships include:
ALTOS-LABS-INCALTOS-LABS-INCCustomer90%
AMGEN-INCAMGEN-INCCustomer90%
+11 more relationships locked
Subscribe — View plans →